HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

PURPOSE: We examined associations between tumor characteristics (human epidermal growth factor receptor 2 [HER2] protein expression, HER2 gene and chromosome 17 copy number, hormone receptor status) and disease-free survival (DFS) of patients in the N9831 adjuvant trastuzumab trial. PATIENTS AND MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Perez, Edith A., Reinholz, Monica M., Hillman, David W., Tenner, Kathleen S., Schroeder, Matthew J., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Harris, Lyndsay N., Gralow, Julie R., Dueck, Amylou C., Ketterling, Rhett P., Ingle, James N., Lingle, Wilma L., Kaufman, Peter A., Visscher, Daniel W., Jenkins, Robert B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954132/
https://ncbi.nlm.nih.gov/pubmed/20697084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.2154
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados